Empowering People to Lead Healthy Lives: Glen Tullman, CEO, Livongo
The Real Chemistry Podcast
00:00
From a $30 Million Company to IPO: The Journey of Allscripts
This chapter discusses the growth and challenges faced by Allscripts, from being a $30 million company to becoming a $1.4 billion company. It explores the business problems they solved, their expansion into practice management, and the importance of having a strong business and partners.
Transcript
Play full episode
